Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Other neutral amino acid transporters refers to a heterogeneous group of solute carrier (SLC) proteins that facilitate the movement of neutral amino acids across biological membranes, distinct from the primary System A, N, and L transporters. This group primarily includes members of the SLC6 family, such as SLC6A19 (B0AT1), SLC6A15 (B0AT2), and SLC6A14 (ATB0,+), as well as the SLC36 family of proton-coupled amino acid transporters (PATs) [1][2]. These proteins are vital for the absorption of essential amino acids in the gut, their reabsorption in the kidneys, and their transport across the blood-brain barrier [3]. For instance, SLC6A19 is the major transporter for neutral amino acids in the intestine, and its deficiency leads to Hartnup disease, a condition characterized by skin rashes and cerebellar ataxia due to tryptophan depletion [4]. In oncology, SLC6A14 is frequently upregulated in cancers of the breast, colon, and pancreas to satisfy the increased demand for amino acids required for rapid proliferation [5]. Therapeutic strategies targeting these transporters include the development of SLC6A19 inhibitors for treating metabolic disorders like obesity and type 2 diabetes, and SLC6A14 inhibitors as potential anti-cancer agents [6][7]. However, the high degree of homology among SLC transporters and their broad expression patterns pose significant challenges for achieving drug selectivity and avoiding systemic toxicity [8].
Inhibition of amino acid transport via competitive or non-competitive binding to the transporter's substrate-binding site, thereby reducing the intracellular availability of specific neutral amino acids and modulating downstream metabolic or signaling pathways.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other neutral amino acid transporters.